FDA Approval: New Drugs & Medical Devices Content Archive

15 posts · Page 1 of 1

1. Four Oncology Drugs and Two Medical Devices Cleared: FDA Approvals, May 10–17, 20262026-05-17
2. Eight regulatory actions, one dominant sponsor: FDA approvals, May 17–22, 20262026-05-22
3. Datroway leads a landmark week: FDA approvals, May 22–29, 20262026-05-29
4. Triformis leads a quiet week: FDA approvals, May 29–June 5, 20262026-06-05
5. Five FDA actions in five days: approvals, June 6–11, 20262026-06-11
6. FDA clears Penumbra Thunderbolt CAVT — stroke clearance, June 11 20262026-06-12
7. FDA approvals week of June 13–19, 2026: first oral carbapenem, two oncology firsts, and a pediatric sweep2026-06-19
8. FDA approvals: Lumvoa leads 9 actions2026-06-26
9. FDA approvals: Tregzi leads 8 actions2026-07-03
10. FDA approvals: Trutakna leads 8 actions2026-07-10
11. FDA approvals: Lipfendra leads 7 actions2026-07-17
12. FDA approvals: Lytenava, Jideytro and OTC pain combo lead the week2026-07-24
13. FDA approvals: Pluvicto, Simtriyo and Ezplaz lead the July 24–31 ledger2026-07-31
14. FDA approvals: Orzeyful, Tudriqev and mFLUSIVA lead the Aug. 1–7 ledger2026-08-07
15. FDA approvals: Zenbexus, Saphnelo and MRESVIA lead the Aug. 7–14 ledger2026-08-14

Explore more channels on Discover